Procalcitonin as a biomarker of infectious diseases
Author:
Open Access
- 1 January 2013
- journal article
- review article
- Published by Korean Association of Internal Medicine in The Korean Journal of Internal Medicine
- Vol. 28 (3) , 285-291
Abstract
Lee H. Korean J Intern Med. 2013 May;28(3):285-291. http://dx.doi.org/10.3904/kjim.2013.28.3.285Keywords
This publication has 40 references indexed in Scilit:
- Procalcitonin to Guide Initiation and Duration of Antibiotic Treatment in Acute Respiratory Infections: An Individual Patient Data Meta-AnalysisClinical Infectious Diseases, 2012
- Meta-Analysis and Systematic Review of Procalcitonin-Guided Therapy in Respiratory Tract InfectionsAntimicrobial Agents and Chemotherapy, 2011
- Procalcitonin for diagnosis of infection and guide to antibiotic decisions: past, present and futureBMC Medicine, 2011
- Procalcitonin-guided algorithms of antibiotic therapy in the intensive care unit: A systematic review and meta-analysis of randomized controlled trialsCritical Care Medicine, 2010
- Use of Plasma Procalcitonin Levels as an Adjunct to Clinical MicrobiologyJournal of Clinical Microbiology, 2010
- Procalcitonin for guidance of antibiotic therapyExpert Review of Anti-infective Therapy, 2010
- Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trialThe Lancet, 2010
- Procalcitonin for reduced antibiotic exposure in ventilator-associated pneumonia: a randomised studyEuropean Respiratory Journal, 2009
- Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumoniaBMC Infectious Diseases, 2007
- Calcitonin precursors are reliable markers of sepsis in a medical intensive care unitCritical Care Medicine, 2000